托西利祖马布诱导的低纤维蛋白质血症在患有全身发作的青少年异常性关节炎的患者中
Tingyan He1, Jiayun Ling2, Jun Yang2
1Department of Rheumatology and Immunology, Shenzhen Children's Hospital, 7019 Yitian Road, Shenzhen, 518038, China. hetingyan2017@outlook.com.
Scientific reports
|June 3, 2023
概括
托西利祖马布 (TCZ) 治疗全身性青春性异常性关节炎 (SJIA) 经常导致低纤维素原水平的疾病 - - 低纤维素原水平. 尽管如此,TCZ对于SJIA患者通常是安全的,尽管在接受手术或MAS患者中需要评估出血风险.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 临床免疫学临床免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性青少年性异常性关节炎 (SJIA) 是一种慢性儿童性炎症性疾病,通常与升高的IN-6 (IL-6) 水平有关.
- 托西利祖马布 (TCZ) 是一种IL-6受体抑制剂,已被批准用于SJIA治疗.
- 在成年人中记录了TCZ诱导的低纤维蛋白质血症,但在SJIA中没有很好的特征.
研究的目的:
- 为了确定SCIA患者中TCZ诱导的低纤维素生成血的发生率.
- 为了研究低纤维素生成症对TCZ治疗的SJIA患者出血风险的潜在影响.
主要方法:
- 在深儿童医院接受TCZ治疗的SJIA患者的回顾性审查.
- 纳入标准:TCZ治疗期间血清纤维素水平的可用性.
- 收集的数据:临床表现,实验室参数,管理和sJADAS10-ESR分数在TCZ启动后的指定间隔.
主要成果:
- 包括十七名SJIA患者;76.47% (13/17) 患有低纤维素生成血症.
- 七名患者 (41.17%) 的血清纤维素水平低于1.5g/L.
- 只有一个患者出现轻度出血; 继续TCZ并没有持续恶化低纤维素生成血症或与疾病活性评分相关.
结论:
- 在SJIA患者中,TCZ单疗可以诱导低纤维素生成血症.
- 对于大多数SJIA患者来说,TCZ治疗似乎是安全的,尽管有低纤维素生成血.
- 患有外科指示或MAS的患者需要在TCZ治疗期间定期评估出血风险.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
204
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
204
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
Inflammatory Bowel Disease IV: Pharmacological Management
159
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
159
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
Fibril-associated Collagen
2.6K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
2.6K


